Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Deferasirox
Medication labelDeferasirox tablets for oral suspension are indicated for the treatment of chronic iron overload due to blood transfusions (transfusional…
Why this: Advisory · dailymed-prescription
Deferasirox tablets for oral suspension are indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older. Deferasirox tablets for oral suspension are indicated for the treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndromes and with a liver iron concentration (LIC) of at least 5 milligrams of iron per gram of liver dry weight (mg Fe/g dw) and a serum ferritin greater than 300 mcg/L. The safety and efficacy of deferasirox tablets for oral suspension when administered with other iron chelation therapy have not been established.
- generic_name
- deferasirox
- product_names
- Deferasirox
- ndc
- 69539-021, 69539-022, 69539-023, 69539-021-30, 69539-021-90, 69539-021-99, 69539-021-11, 69539-021-06, 69539-022-30, 69539-022-90, 69539-022-99, 69539-022-11, 69539-022-06, 69539-023-30, 69539-023-90, 69539-023-05, 69539-023-11, 69539-023-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en